文献速递毛发、甲与色素性疾病

美国雇主保险人群成人及儿童斑秃、全秃与普秃的患病率和发病率趋势

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
PubMed 文献 · JAMA Dermatol · 2023-01-01

这项基于美国IBM MarketScan商业保险及Medicare补充数据库的回顾性人群队列研究(2016-2019年)显示,斑秃患病率从2016年的0.199%升至2019年的0.222%,全秃/普秃患病率从0.012%升至0.019%;斑秃发病率为每10万人年87.39至92.90,全秃/普秃为7.09至8.92。女性、成人及东北部地区患病率和发病率更高。

要点

  • 斑秃患病率从2016年0.199%升至2019年0.222%,全秃/普秃从0.012%升至0.019%。
  • 斑秃发病率每10万人年87.39(2017年)至92.90(2019年),全秃/普秃为7.09(2017年)至8.92(2016年)。
  • 约5%至10%的斑秃现患和 incident 病例为全秃/普秃。

核心结论

  • 研究结果表明,近期斑秃患病率和发病率估计有助于增进对疾病负担的理解。
  • 需要进一步研究以阐明亚人群差异及更广泛美国人群中的斑秃趋势。

研究设计与样本

  • 回顾性、基于人群的队列研究,纳入2016年1月至2019年12月IBM MarketScan商业理赔与 encounters 及Medicare补充数据库的参保者及其家属,要求每个研究日历年及前一年均有保险计划入组。

主要发现

  • 斑秃患病率从2016年0.199%(95%CI 0.198%-0.200%)升至2019年0.222%(95%CI 0.221%-0.223%)。
  • 全秃/普秃患病率从2016年0.012%(95%CI 0.012%-0.013%)升至2019年0.019%(95%CI 0.018%-0.019%)。
  • 斑秃发病率每10万人年从2017年87.39(95%CI 86.84-87.96)至2019年92.90(95%CI 92.35-93.45)。
  • 全秃/普秃发病率每10万人年从2017年7.09(95%CI 6.94-7.25)至2016年8.92(95%CI 8.75-9.09)。
  • 女性较男性、成人较儿童和青少年、东北部较其他地区斑秃及全秃/普秃患病率和发病率更高。

局限性

  • 需要进一步研究以阐明亚人群差异及更广泛美国人群中的斑秃趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Alopecia areata (AA) is characterized by nonscarring hair loss of the scalp, face, and/or body. Alopecia totalis (AT) and alopecia universalis (AU) involve complete loss of the scalp and body hair, respectively. The epidemiology of AA in the US remains unclear, having previously been extrapolated from older studies that were limited to specific geographic areas or clinical settings, or from self-reported data. OBJECTIVE: To estimate the annual prevalence and incidence of AA and AT and/or AU (AT/AU) in the US. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, population-based cohort study was conducted from January 2016 to December 2019 and included enrollees in the IBM MarketScan Commercial Claims and Encounters and Medicare Supplemental databases and their dependents, with plan enrollment during each study calendar year and the year prior. EXPOSURES: Prevalent cases were identified by 1 or more claims for AA or AT/AU (International Statistical Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM] codes L63.x, L63.0, L63.1) during each year of interest or the year prior. Incident cases were identified by 1 or more claims for AA or AT/AU during a specific year and no diagnosis the year prior. MAIN OUTCOMES AND MEASURES: Annual incidence and prevalence rates were calculated and stratified by age, sex, and region. National employer-sponsored insurance population estimates were obtained using population-based weights. RESULTS: Among eligible patients (2016: n = 18 368 [mean (SD) age, 40.6 (17.9) years; 12 295 women (66.9%)]; 2017: n = 14 372 [mean (SD) age, 39.6 (17.7) years; 9195 women (64.0%)]; 2018: n = 14 231 [mean (SD) age, 38.9 (17.3) years; 8998 women (63.2%)]; 2019: n = 13 455 [mean (SD) age, 39.1 (17.4) years; 8322 women (61.9%)]), AA prevalence increased from 0.199% (95% CI, 0.198%-0.200%) in 2016 to 0.222% (95% CI, 0.221%-0.223%) in 2019. Roughly 5% to 10% of prevalent and incident cases of AA were AT/AU. The prevalence of AT/AU increased from 0.012% (95% CI, 0.012%-0.013%) to 0.019% (95% CI, 0.018%-0.019%) from 2016 to 2019. Incidence of AA per 100 000 person-years ranged from 87.39 (95% CI, 86.84-87.96) in 2017 to 92.90 (95% CI, 92.35-93.45) in 2019. Incidence of AT/AU ranged from 7.09 (95% CI, 6.94-7.25) in 2017 to 8.92 (95% CI, 8.75-9.09) in 2016. Prevalence and incidence of AA and AT/AU were higher among female vs male individuals, adults vs children and adolescents, and in the Northeast vs other regions. CONCLUSIONS AND RELEVANCE: The results of this cohort study suggest that these recent AA prevalence and incidence estimates could help improve current understanding of the disease burden. Further research is warranted to elucidate subpopulation differences and trends in AA in the broader US population.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Mostaghimi A, Gao W, Ray M, et al. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population. JAMA Dermatol. 2023. PMID: 36857069. doi:10.1001/jamadermatol.2023.0002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。